Literature DB >> 17408212

Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.

Amol Paharia1, Awesh K Yadav, Gopal Rai, Sunil K Jain, Shyam S Pancholi, Govind P Agrawal.   

Abstract

An objective of the present investigation was to prepare and evaluate Eudragit-coated pectin microspheres for colon targeting of 5-fluorouracil (FU). Pectin microspheres were prepared by emulsion dehydration method using different ratios of FU and pectin (1:3 to 1:6), stirring speeds (500-2000 rpm) and emulsifier concentrations (0.75%-1.5% wt/vol). The yield of preparation and the encapsulation efficiencies were high for all pectin microspheres. Microspheres prepared by using drug:polymer ratio 1:4, stirring speed 1000 rpm, and 1.25% wt/vol concentration of emulsifying agent were selected as an optimized formulation. Eudragit-coating of pectin microspheres was performed by oil-in-oil solvent evaporation method using coat:core ratio (5:1). Pectin microspheres and Eudragit-coated pectin microspheres were evaluated for surface morphology, particle size and size distribution, swellability, percentage drug entrapment, and in vitro drug release in simulated gastrointestinal fluids (SGF). The in vitro drug release study of optimized formulation was also performed in simulated colonic fluid in the presence of 2% rat cecal content. Organ distribution study in albino rats was performed to establish the targeting potential of optimized formulation in the colon. The release profile of FU from Eudragit-coated pectin microspheres was pH dependent. In acidic medium, the release rate was much slower; however, the drug was released quickly at pH 7.4. It is concluded from the present investigation that Eudragit-coated pectin microspheres are promising controlled release carriers for colon-targeted delivery of FU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408212      PMCID: PMC2750447          DOI: 10.1208/pt0801012

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Pectin-based microspheres: a preformulatory study.

Authors:  E Esposito; R Cortesi; G Luca; C Nastruzzi
Journal:  Ann N Y Acad Sci       Date:  2001-11       Impact factor: 5.691

2.  Salicylazobenzoic acid in ulcerative colitis.

Authors:  A Bartalsky
Journal:  Lancet       Date:  1982-04-24       Impact factor: 79.321

Review 3.  Targeting drugs to the colon: delivery systems for oral administration.

Authors:  M Ashford; J T Fell
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

4.  Hydrogels for controlled drug delivery.

Authors:  N B Graham; M E McNeill
Journal:  Biomaterials       Date:  1984-01       Impact factor: 12.479

5.  Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.

Authors:  G Rai; S K Jain; S Agrawal; S Bhadra; S S Pancholi; G P Agrawal
Journal:  Pharmazie       Date:  2005-02       Impact factor: 1.267

6.  Biodegradable progesterone microsphere delivery system for osteoporosis therapy.

Authors:  Q Yang; G Owusu-Ababio
Journal:  Drug Dev Ind Pharm       Date:  2000-01       Impact factor: 3.225

7.  The relation between swelling properties and enzymatic degradation of azo polymers designed for colon-specific drug delivery.

Authors:  G Van den Mooter; C Samyn; R Kinget
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  Design of microencapsulated chitosan microspheres for colonic drug delivery.

Authors:  M L Lorenzo-Lamosa; C Remuñán-López; J L Vila-Jato; M J Alonso
Journal:  J Control Release       Date:  1998-03-02       Impact factor: 9.776

9.  In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.

Authors:  A Rubinstein; R Radai; M Ezra; S Pathak; J S Rokem
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.

Authors:  Sandip B Tiwari; T Krishna Murthy; M Raveendra Pai; Pavak R Mehta; Pasula B Chowdary
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

View more
  24 in total

1.  Spray Dried Formulation of 5-Fluorouracil Embedded with Probiotic Biomass: In Vitro and In Vivo Studies.

Authors:  Anshul Sharma; Malika Arora; Amit K Goyal; Goutam Rath
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

2.  Novel polymeric composites based on carboxymethyl chitosan and poly(acrylic acid): in vitro and in vivo evaluation.

Authors:  Qurat-Ul-Ain Sharif; Muhammad Sohail; Mahmood Ahmad; Muhammad Usman Minhas; Shahzeb Khan; Samiullah Khan; Mubeen Kousar
Journal:  J Mater Sci Mater Med       Date:  2017-08-19       Impact factor: 3.896

3.  Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.

Authors:  Mayur M Patel
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 4.  Pectin matrix as oral drug delivery vehicle for colon cancer treatment.

Authors:  Tin Wui Wong; Gaia Colombo; Fabio Sonvico
Journal:  AAPS PharmSciTech       Date:  2010-12-31       Impact factor: 3.246

5.  Multiparticulate system for colon targeted delivery of ondansetron.

Authors:  S Jose; K Dhanya; T A Cinu; N A Aleykutty
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

6.  Formulation, evaluation and optimization of pectin- bora rice beads for colon targeted drug delivery system.

Authors:  Kuldeep Hemraj Ramteke; Lilakant Nath
Journal:  Adv Pharm Bull       Date:  2013-12-24

7.  Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.

Authors:  Alaa Eldeen B Yassin; Md Khalid Anwer; Hammam A Mowafy; Ibrahim M El-Bagory; Mohsen A Bayomi; Ibrahim A Alsarra
Journal:  Int J Med Sci       Date:  2010-11-22       Impact factor: 3.738

8.  Eudragit(®) microparticles for the release of budesonide: a comparative study.

Authors:  Rita Cortesi; Laura Ravani; Enea Menegatti; Elisabetta Esposito; F Ronconi
Journal:  Indian J Pharm Sci       Date:  2012-09       Impact factor: 0.975

9.  Hyaluronan-cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery.

Authors:  Shiao-Wen Tsai; Ding-Syuan Yu; Shu-Wei Tsao; Fu-Yin Hsu
Journal:  Int J Nanomedicine       Date:  2013-07-03

10.  Factorial design-based development of measlamine microspheres for colonic delivery.

Authors:  Vikas Jain; Dayal Prasad; Deepika Jain; Santosh Kumar Mishra; Ranjit Singh
Journal:  Biomatter       Date:  2011 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.